feed,title,long_url,short_url
Investing,Neurocrine shares target raised to $200 on M4 agonist optimism,https://www.investing.com/news/stock-market-news/neurocrine-shares-target-raised-to-200-on-m4-agonist-optimism-93CH-3335128,https://da.gd/iyEg
